Albany, NY -- (SBWIRE) -- 01/02/2015 -- The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.

View Full Report
http://www.marketresearchreports.biz/analysis/232428

India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process Validation: General Principles and Practices'. While countries such as Japan and Singapore are signatories to the ICH Q7 regulation, India and China follow their national GMP guidelines. The efficiency and expertise of Asian contract manufacturers have positioned them in a very strategic space in the global pharmaceutical supply chain, with a vast majority of the APIs and intermediates being sourced from markets such as India and China.

Download Detail Report With Complete TOC
http://www.marketresearchreports.biz/sample/sample/232428

DelveInsight's, Obsessive-Compulsive Disorder -API Insights, 2014 Report describes the current therapeutics that are propelling the pharmaceutical markets worldwide. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the Obsessive-Compulsive Disorder. It also provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent and patent exclusivity information. The research analysis also presents the global sales forecasts data till 2015.

Explore All Latest Published Reports By Daedal Research
http://www.marketresearchreports.biz/publisher/102

DATA SOURCES

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE

* A snapshot of the global Market therapeutics scenario for Obsessive-Compulsive Disorder.

* A review of the marketed products under prescription for Obsessive-Compulsive Disorder, regulatory information and marketing status.

* Coverage of global patent coverage and detailed commentaries on the US patent challenges.

* Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

* Product profiles for marketed products for Obsessive-Compulsive Disorder with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

* Coverage of API Manufacturers for Obsessive-Compulsive Disorder drugs in the United States, Europe and Asian Regions with location details.

* Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Obsessive-Compulsive Disorder drugs.

* Key discontinued Marketed products.

* Global Sales Figure from 2011-2015.

REASONS TO BUY

* Evaluate the marketing status and exclusivity details of Obsessive-Compulsive Disorder key products to exploit opportunities for generic drug development opportunities.

* Key players in the pharmaceutical industry.

* Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.

* Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Obsessive-Compulsive Disorder.

* API intelligence over marketed drugs for Obsessive-Compulsive Disorder and gaining primary intelligence over active ingredients manufacturers across the globe.

* Uncovering opportunities in the rapidly growing the US markets.

Related Reports

Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014

View Full Report
http://www.marketresearchreports.biz/analysis/238014

Summary

GlobalData's clinical trial report, Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014" provides data on the Onchocerciasis (River Blindness) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Onchocerciasis (River Blindness).

Download Detail Report With Complete TOC
http://www.marketresearchreports.biz/sample/sample/238014

It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Onchocerciasis (River Blindness). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Mycoses Global Clinical Trials Review, H2, 2014

View Full Report
http://www.marketresearchreports.biz/analysis/238015

Summary

GlobalData's clinical trial report, Mycoses Global Clinical Trials Review, H2, 2014" provides data on the Mycoses clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Mycoses. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe.

Download Detail Report With Complete TOC
http://www.marketresearchreports.biz/sample/sample/238015

The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Mycoses. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

About MarketResearchReports.biz
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz

Contact Us:
Office: State Tower
90 Sate Street, Suite 700
Albany, NY 12207
United States
Tel: 518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: sales@marketresearchreports.biz